Home › Chronic Lymphocytic Leukemia › New York › Buffalo
Chronic Lymphocytic Leukemia clinical trials in Buffalo, NY
4 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Buffalo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
RecruitingPhase 2
- Roswell Park Cancer Institute, Buffalo
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
RecruitingPhase 3
- Roswell Park Cancer Institute ( Site 0023), Buffalo
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
- Roswell Park Comprehensive Cancer Center, Buffalo
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA31 studies
- Columbus, OH28 studies
- Durham, NC27 studies
- Washington, DC22 studies
- Seattle, WA20 studies
- Rochester, MN19 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Milwaukee, WI15 studies
- Cincinnati, OH14 studies
- Chicago, IL14 studies
Other studies in Buffalo
- Cancer (all types)19 studies
- Acute Myeloid Leukemia19 studies
- Non-Small Cell Lung Cancer18 studies
- Lung Cancer16 studies
- Breast Cancer16 studies
- Ovarian Cancer13 studies
- Prostate Cancer11 studies
- Metastatic Cancer11 studies
- Multiple Myeloma10 studies
- Melanoma10 studies
- Obesity9 studies
- Burkitt Lymphoma8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.